NIAGEN BIOSCIENCE, INC.: interest expense
Interest expense for NIAGEN BIOSCIENCE, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All NIAGEN BIOSCIENCE, INC. financial histories
What this measure means
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
Exact concept: us-gaap:InterestExpense. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-01-03 to 2021-12-31. The SEC response was captured on 2026-09-20.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2021-01-01 | 2021-12-31 | 55,000 | USD | 2022-03-14 | 10-K · 0001628280-22-006041 |
| 2020-01-01 | 2020-12-31 | 71,000 | USD | 2022-03-14 | 10-K · 0001628280-22-006041 |
| 2019-01-01 | 2019-12-31 | 847,000 | USD | 2021-03-12 | 10-K · 0001654954-21-002692 |
| 2017-12-31 | 2018-12-31 | 79,000 | USD | 2020-03-10 | 10-K · 0001654954-20-002437 |
| 2017-01-01 | 2017-12-30 | 153,000 | USD | 2019-03-07 | 10-K · 0001654954-19-002395 |
| 2016-01-03 | 2016-12-31 | 333,286 | USD | 2018-03-15 | 10-K · 0001654954-18-002621 |
| 2015-01-04 | 2016-01-02 | 566,917 | USD | 2018-03-15 | 10-K · 0001654954-18-002621 |
| 2013-12-29 | 2015-01-03 | 158,849 | USD | 2017-03-16 | 10-K · 0001654954-17-002092 |
| 2012-12-30 | 2013-12-28 | 34,330 | USD | 2016-03-17 | 10-K · 0001415889-16-005140 |
| 2012-01-01 | 2012-12-29 | 29,006 | USD | 2014-03-27 | 10-K · 0001415889-14-000961 |
| 2011-01-02 | 2011-12-31 | -32,142 | USD | 2013-03-29 | 10-K · 0001415889-13-000560 |
| 2010-01-03 | 2011-01-01 | 36,068 | USD | 2012-03-15 | 10-K · 0001415889-12-000348 |
Related financial histories
- NIAGEN BIOSCIENCE, INC.: total assets
- NIAGEN BIOSCIENCE, INC.: total liabilities
- NIAGEN BIOSCIENCE, INC.: stockholders equity
- NIAGEN BIOSCIENCE, INC.: cash and cash equivalents
- NIAGEN BIOSCIENCE, INC.: net income or loss
- NIAGEN BIOSCIENCE, INC.: operating cash flow
- NIAGEN BIOSCIENCE, INC.: capital expenditure payments
- NIAGEN BIOSCIENCE, INC.: revenue
- NIAGEN BIOSCIENCE, INC.: financing cash flow
- NIAGEN BIOSCIENCE, INC.: investing cash flow
- NIAGEN BIOSCIENCE, INC.: retained earnings or deficit
- NIAGEN BIOSCIENCE, INC.: basic weighted-average shares
- NIAGEN BIOSCIENCE, INC.: diluted weighted-average shares
- NIAGEN BIOSCIENCE, INC.: basic earnings per share
- NIAGEN BIOSCIENCE, INC.: diluted earnings per share
- NIAGEN BIOSCIENCE, INC.: income tax expense or benefit
- NIAGEN BIOSCIENCE, INC.: net property, plant and equipment
- NIAGEN BIOSCIENCE, INC.: share-based compensation expense
- NIAGEN BIOSCIENCE, INC.: operating income or loss
- NIAGEN BIOSCIENCE, INC.: current assets
- NIAGEN BIOSCIENCE, INC.: current liabilities
- NIAGEN BIOSCIENCE, INC.: current accounts payable
- NIAGEN BIOSCIENCE, INC.: net finite-lived intangible assets
- NIAGEN BIOSCIENCE, INC.: net current accounts receivable
- NIAGEN BIOSCIENCE, INC.: common-stock repurchase payments
- NIAGEN BIOSCIENCE, INC.: operating expenses
- NIAGEN BIOSCIENCE, INC.: net inventory
- NIAGEN BIOSCIENCE, INC.: gross profit
- NIAGEN BIOSCIENCE, INC.: cost of revenue
- NIAGEN BIOSCIENCE, INC.: research and development expense
Inspect the source
- Entity
- NIAGEN BIOSCIENCE, INC. / CIK 0001386570
- Captured
- 2026-09-20T07:59:02.162Z
- SEC response SHA-256
94352bf8b6f04074c9aa98cd63fa97055bc3335ae039584aee12f63320ac36f6
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001386570.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))